UniX AI Unveils Panther Wheeled Dual-Arm Humanoid Robot and Begins Global Deliveries for Real-World Service Applications
UniX AI, a global humanoid robotics service provider specializing in R&D, mass production, and real-world deployment…
Healthcare & Life Sciences
Dr. Safa S. Kassab Performs First U.S. Total Knee Replacement Using Pixee Medical’s Knee+ NexSight AR Glasses
Orthopedic Specialists of Oakland County (OSOC) announced that Dr. Safa S. Kassab has become the first surgeon in the Un…
Dr. Kornelis Poelstra Completes 2,000th Robotic-Assisted Spine Procedure in Las Vegas
The Robotic Spine Institute of Las Vegasannounced that Dr. Kornelis Poelstra, MD, PhD, a spine surgeon fellowship-trai…
WuXi XDC Achieves GMP Release for Singapore BCM3, Advancing Global Bioconjugate Manufacturing Capacity
WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturin…
Ping An Unveils AI Innovations Across Healthcare, Insurance and Payments at WAIC 2026
Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; unveiled a range of in…
Andelyn Biosciences to Scale Up Genprex’s AAV-Based Diabetes Gene Therapy Program
Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has s…
Inventiva Completes Phase 3 NATiV3 Trial of Lanifibranor in MASH
Inventiva(“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on…
Resonant Clinical Solutions Acquires Creapharm Bioservices to Expand European Biorepository Capabilities
Resonant Clinical Solutions, a global clinical solutions partner serving life sciences organizations across the clinic…
AtomVie Opens $160 Million Radiopharmaceutical Facility in Ontario
AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the…
Tarsus Completes Acquisition of Alkeus, Adding Phase 3 Stargardt Disease Therapy ALK-001
Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying b…
Nanox Expands US Commercial Reach With New England Distribution Partnership for Nanox.ARC
Nano-X Imaging Ltd. (“Nanox”, or the “Company”, a leader in innovative medical imaging technol…
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered IPF Drug Rentosertib
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced…
Lonza to Build Large-Scale Commercial Spray-Drying Facility in Oregon to Expand US Manufacturing Capacity
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced plans to …
Leveragen Secures Australian Patent for Singularity Platform Advancing In Vivo Antibody Discovery
Leveragen, Inc., a Boston-based biotechnology company advancing in vivo antibody discovery, announced the grant …
Scottish Brain Sciences Launches Accredited Alzheimer’s Biomarker Testing Laboratory in Scotland
Scottish Brain Sciences (SBS) has launched a new and accredited clinical laboratory service offering blood‑bas…
Anivive Wins Full FDA Approval for Laverdia, Expanding At-Home Lymphoma Treatment for Dogs
Anivive Lifesciences announced that the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine has gra…
Skye Bioscience to Acquire Redx Pharma and Launch Fibrx Therapeutics With $125 Million Financing
Skye Bioscience, Inc., and Redx Pharma Limited (“Redx”), a U.K. based, privately-held clinical-stage biote…
SK pharmteco Expands Swords Campus With New Small-Molecule and HPAPI Facilities
SK pharmteco recently hosted a formal ribbon-cutting ceremony to mark the official opening of two major facility expan…
Leveragen Strengthens Singularity Platform IP with Australian Patent Grant
Leveragen, Inc., a Boston-based biotechnology company advancing in vivo antibody discovery, today announced the grant …
Alebund Pharmaceuticals’ AP301 Phosphate Binder NDA Accepted for Review in China
Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical…
InnoCare Pharma Gains Approval for Phase III Trial of Mesutoclax Combination in Newly Diagnosed AML
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, anno…
HUTCHMED Reports Positive Phase III Results for ORPATHYS and TAGRISSO Combination in EGFR-Mutated Lung Cancer
HUTCHMED (China) Limited announces positive high-level results from the SANOVO China Phase III trial in treatment-na&i…
Rezubio Advances RZ-520 Into Phase 1 Clinical Trial After FDA and NMPA Clearances
Rezubio announced that it has successfully completed dosing of the first cohort in its Phase 1 clinical trial fol…
GCCL Expands Asia-Pacific Clinical Trial Partnerships at Asia Bio Partnering Forum 2026
GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, announced …
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered IPF Drug Rentosertib
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced…